1.
The Restrictions of Representations of the Special Linear Group to Subsystem Subgroups of Type A 2
by A. A. Osinovskaya
Journal of mathematical sciences (New York, N.Y.), 2018, Vol.234 (2), p.203-218
2.
Picard groups of higher real -theory spectra at height
by Heard, Drew
Compositio mathematica, 2017, Vol.153 (9), p.1820-1854
3.
Finite p-groups All of Whose Minimal Nonabelian Subgroups are Nonmetacyclic of Order p 3
by Qin Hai Zhang
Acta mathematica Sinica. English series, 2019, Vol.35 (7), p.1179-1189
4.
Anosov representations: domains of discontinuity and applications
by Guichard, Olivier
Inventiones mathematicae, 2012, Vol.190 (2), p.357-438
5.
Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials
by Fan, Jingchun
Journal of clinical epidemiology, 2019, Vol.108, p.17-25
6.
Regular Unipotent Elements from Subsystem Subgroups of Type A 2 in Representations of the Special Linear Groups
by Osinovskaya, A. A.
Journal of mathematical sciences (New York, N.Y.), 2016, Vol.219 (3), p.473-483
7.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
by Balar, Arjun V, Dr
The Lancet (British edition), 2016, Vol.389 (10064), p.67-76
8.
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
by Crona, Joakim
Endocrine reviews, 2017, Vol.38 (6), p.489-515
9.
Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
by Vardakas, Konstantinos Z
The Lancet infectious diseases, 2018, Vol.18 (1), p.108-120
10.
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
by Tutt, Andrew
Nature medicine, 2018, Vol.24 (5), p.628-637
11.
Stability in the homology of congruence subgroups
by Putman, Andrew
Inventiones mathematicae, 2015, Vol.202 (3), p.987-1027
12.
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
by Drilon, Alexander
Nature medicine, 2020, Vol.26 (1), p.47-51
13.
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
by Denkert, Carsten, Dr
The Lancet (British edition), 2016, Vol.389 (10087), p.2430-2442
14.
Controversy and debate on dengue vaccine series—paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccina...
by Dans, Antonio L
Journal of clinical epidemiology, 2018, Vol.95, p.137-139
15.
New Supercharacter Theory for Sylow Subgroups in Orthogonal and Symplectic Groups
by Panov, A. N
Journal of mathematical sciences (New York, N.Y.), 2019, Vol.243 (4), p.612-623
16.
Periods of automorphic forms: the case of $(\text{GL}_{n+1}\times \text{GL}_{n},\text{GL}_{n})
by Ichino, Atsushi
Compositio mathematica, 2015, Vol.151 (4), p.665-712
17.
Artin groups of Euclidean type
by McCammond, Jon
Inventiones mathematicae, 2017, Vol.210 (1), p.231-282
18.
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
by Barrett, Jordan R
Nature medicine, 2021, Vol.27 (2), p.279-288
19.
Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies
by Olsen, Mette Frahm
Journal of clinical epidemiology, 2018, Vol.101, p.87-106.e2
20.
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
by Schuetz, Philipp
The Lancet infectious diseases, 2018, Vol.18 (1), p.95-107
